国际麻醉学与复苏杂志   2025, Issue (4): 0-0
    
输注小剂量艾司氯胺酮复合环泊酚用于老年患者结直肠内镜黏膜下剥离术的有效性和安全性研究
连一闻, 马艳辉, 孔萃萃, 吴洁, 王天龙1()
1.首都医科大学宣武医院 麻醉科
Effectiveness and safety of low dose esketamine combined with cyclopofol infusion in elderly patients undergoing endoscopic submucosal dissection
 全文:
摘要:

目的 探讨输注小剂量艾司氯胺酮复合环泊酚用于老年患者结直肠内镜下黏膜剥离术(endoscopic submucosal dissection, ESD)的有效性和安全性研究。方法 择期行内镜下结直肠ESD患者60例,年龄65~75岁,BMI 18~28kg/m2,ASA I~III级。按照随机数字表法将患者分为两组:艾司氯胺酮组(E组)及瑞芬太尼组(R组)。麻醉诱导前E组和R组分别静注0.1mg/kg艾司氯胺酮及0.4μg/kg瑞芬太尼,30s后均静注0.4mg/kg环泊酚进行麻醉诱导。E组采用持续输注环泊酚0.8~1mg·kg-1·h-1及艾司氯胺酮0.1~0.2 mg·kg-1·h-1进行麻醉维持,R组采用持续输注环泊酚0.8~1mg·kg-1·h-1及瑞芬太尼0.05~0.1mg·kg-1·min-1进行麻醉维持。记录诱导时间、苏醒时间、离室时间及手术时间;记录环泊酚用量、血管活性药物使用情况;记录麻醉前(T0)、诱导后1min(T1)、置入肠镜(T2)、黏膜下剥离(T3)、创面处理(T4)、苏醒(T5)时HR、MAP、SpO2、RR、IoC1及IoC2;记录术中及术后不良反应发生情况;记录术后15min 、2h、4h及24h静息VAS评分及术后麻醉医师、内镜医师和患者满意度评分。结果 与R组比较,E组术中低血压及呼吸抑制发生率明显降低,麻黄碱及去甲肾上腺素使用率明显降低(P0.05);与R组比较,E组术中MAP、RR及SpO2较高(P0.05);与R组比较,E组内镜医师满意度评分增高(P0.05)。两组患者术中心动过缓及体动发生率、术中环泊酚、阿托品用量以及术中不同时间点HR、IoC1、IoC2值、术后不良反应发生情况比较,差异无统计学意义(P0.05)。结论 输注小剂量艾司氯胺酮复合环泊酚可安全有效的用于老年患者结直肠ESD手术,且血流动力学波动小,呼吸抑制少,内镜医师满意度评分高。

关键词: 老年;艾司氯胺酮;输注;环泊酚;内镜黏膜下剥离术
Abstract:

Objective To investigate the effectiveness and safety of low dose esketamine combined with ciprofol infusion in elderly patients undergoing endoscopic submucosal dissection (ESD). Methods 60 patients with endoscopic colorectal ESD, aged 65-75 years, BMI18-28kg/m2, ASA grade I-III, were selected. Patients were divided into two groups according to random number table method: esketamine group (group E) and remifentanil group (group R). Group E was given 0.1mg/kg esketamine and ciprofol 0.4 mg/kg for anesthesia onset, group R was given 0.4 μg/kg remifentani and ciprofol 0.4 mg/kg for anesthesia onset. Anesthesia maintenance was administered with esketamine 0.1-0.2 mg·kg-1·h-1 and ciprofol 0.8-1mg·kg-1·h-1 in group E, while anesthesia was maintained with remifentanil 0.05~0.1mg·kg-1·min-1 and ciprofol 0.8-1mg·kg-1·h-1 in group R. The induction time, awakening time, departure time and surgical time were recorded. The dosage of ciprofol and cases of using vasoactive drugs were recorded. The occurrence of intraoperative and postoperative adverse events were recorded. HR, MAP, SpO2, RR, IoC1 and IoC2 were recorded before anesthesia (T0), 1min after induction (T1), colonoscopy implantation (T2), submucosal dissection (T3), wound treatment (T4), and recovery (T5). The VAS score of 15min/2hours/4hours/24hous after surgery, satisfaction of anesthesiologist, endoscopist and patient were recorded. Results Compared with group R, the incidence of intraoperative hypotension and respiratory depression was decreased in group E, dosages of norepinephrine and ephedrine were decreased (P0.05), MAP, RR and SpO2 were higher (P0.05), and endoscopists' satisfaction was higher (P0.05). There were no significant differences between the two groups in the incidence of intraoperative bradycardia and motor incidence, dosage of ciprofol and atropine, intraoperative HR,BIS,IoC1 and IoC2 incidence of postoperative adverse reactions (P0.05). Conclusions Low-dose esketamine combined with ciprofol infusion is safe and effective for elderly patients undergoing ESD, while the hemodynamic fluctuation and respiratory depression is less with higher satisfaction score of endoscopist.

Key words: Elderly; Esketamine; Infusion; Ciprofol; Endoscopic Submucosal Dissection